REXPONDA Canadian Trademark Information
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, metabolic disorders, stroke, cancer, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, anti-psychotics, central nervous system depressants, central nervous system stimulants; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents.
Perfect for these industries
Words that describe this mark
pharmaceutical preparations human use treatment prevention obesity diabetes incontinence cardiovascular diseases metabolic disorders stroke cancer autoimmune diseases solid organ transplant rejection pharmaceutical preparations human use antibiotics
Abandonment Notice!
On Wednesday, January 5, 2011,
status on the REXPONDA
trademark changed to Interruption of proceeding.
Apply Now for this name starting at $449!
CAUTION: Although Canada registration for this particular filing is inactive,
the mark may still enjoy common law rights, or may have been applied for again in a separate application.
Further research may be warranted to determine where this mark is truly abandoned in commerce.
On Friday, December 16, 2005, a canadian trademark registration was filed for
REXPONDA by Bristol-Myers Squibb Company,
*********, **********, ***** ****.
The Canadian IP office has given the trademark application number of
1283382.
The current status of this trademark filing is Interruption of proceeding.
The REXPONDA
trademark is filed in the description of
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, metabolic disorders, stroke, cancer, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, anti-psychotics, central nervous system depressants, central nervous system stimulants; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents.
.
100% Satisfaction Guarantee
protect your valuable brand now.
Classification Information
Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks.
Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms!
You can
register your trademark in 180+ countries
in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records.
Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.